CPRX - Catalyst Pharmaceuticals Non-GAAP EPS of $0.38 beats by $0.08 revenue of $98.44M misses by $0.33M
2024-05-08 16:47:36 ET
More on Catalyst Pharmaceuticals
- Catalyst Pharmaceuticals: Revenue Growth Lagging Expense Growth (Rating Downgrade)
- Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2023 Earnings Call Transcript
- Catalyst Pharmaceuticals Q1 2024 Earnings Preview
- Citi starts Catalyst at buy, cites rare disease drug portfolio
- Seeking Alpha’s Quant Rating on Catalyst Pharmaceuticals